BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33391544)

  • 1. Tofacitinib restores the balance of γδTreg/γδT17 cells in rheumatoid arthritis by inhibiting the NLRP3 inflammasome.
    Yang X; Zhan N; Jin Y; Ling H; Xiao C; Xie Z; Zhong H; Yu X; Tang R; Ma J; Guan J; Yin G; Wu G; Lu L; Wang J
    Theranostics; 2021; 11(3):1446-1457. PubMed ID: 33391544
    [No Abstract]   [Full Text] [Related]  

  • 2. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.
    Guo C; Fu R; Wang S; Huang Y; Li X; Zhou M; Zhao J; Yang N
    Clin Exp Immunol; 2018 Nov; 194(2):231-243. PubMed ID: 30277570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protectin DX restores Treg/T
    Jin S; Sun S; Ling H; Ma J; Zhang X; Xie Z; Zhan N; Zheng W; Li M; Qin Y; Zhao H; Chen Y; Yang X; Wang J
    Cell Death Dis; 2021 Mar; 12(3):280. PubMed ID: 33723242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner.
    Yang Z; Cao J; Yu C; Yang Q; Zhang Y; Han L
    Joint Bone Spine; 2016 May; 83(3):282-9. PubMed ID: 26775759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α/calreticulin dual signaling induced NLRP3 inflammasome activation associated with HuR nucleocytoplasmic shuttling in rheumatoid arthritis.
    Liu Y; Wei W; Wang Y; Wan C; Bai Y; Sun X; Ma J; Zheng F
    Inflamm Res; 2019 Jul; 68(7):597-611. PubMed ID: 31119302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis.
    Zhao C; Gu Y; Zeng X; Wang J
    Clin Immunol; 2018 Dec; 197():154-160. PubMed ID: 30236770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol inhibits rheumatoid arthritis through the ROS-NF-κB-NLRP3 inflammasome axis.
    Jing M; Yang J; Zhang L; Liu J; Xu S; Wang M; Zhang L; Sun Y; Yan W; Hou G; Wang C; Xin W
    Int Immunopharmacol; 2021 Sep; 98():107879. PubMed ID: 34147915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction.
    Greenhill CJ; Jones GW; Nowell MA; Newton Z; Harvey AK; Moideen AN; Collins FL; Bloom AC; Coll RC; Robertson AA; Cooper MA; Rosas M; Taylor PR; O'Neill LA; Humphreys IR; Williams AS; Jones SA
    Arthritis Res Ther; 2014 Aug; 16(4):419. PubMed ID: 25175678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis.
    Choulaki C; Papadaki G; Repa A; Kampouraki E; Kambas K; Ritis K; Bertsias G; Boumpas DT; Sidiropoulos P
    Arthritis Res Ther; 2015 Sep; 17(1):257. PubMed ID: 26385789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taraxasterol suppresses inflammation in IL-1β-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice.
    Chen J; Wu W; Zhang M; Chen C
    Int Immunopharmacol; 2019 May; 70():274-283. PubMed ID: 30851708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis.
    Yang G; Lee HE; Moon SJ; Ko KM; Koh JH; Seok JK; Min JK; Heo TH; Kang HC; Cho YY; Lee HS; Fitzgerald KA; Lee JY
    Arthritis Rheumatol; 2020 Jul; 72(7):1192-1202. PubMed ID: 32134203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib inhibits granulocyte-macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils.
    Furuya MY; Asano T; Sumichika Y; Sato S; Kobayashi H; Watanabe H; Suzuki E; Kozuru H; Yatsuhashi H; Koga T; Ohira H; Sekine H; Kawakami A; Migita K
    Arthritis Res Ther; 2018 Aug; 20(1):196. PubMed ID: 30157949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A narrative review of positive regulation of NLRP3 inflammasome in rheumatoid arthritis.
    Zhuang Y; Wang H; Su J; Zhang J; Wang Q; Chen Y; Che H
    Ann Palliat Med; 2021 Dec; 10(12):12877-12885. PubMed ID: 35016462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 promotes collagen-induced arthritis by activating the NLRP3 inflammasome through the cathepsin B/S100A9-mediated pathway.
    Wang H; Wang Z; Wang L; Sun L; Liu W; Li Q; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106985. PubMed ID: 33182050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photobiomodulation ameliorates inflammatory parameters in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis.
    Ryu JH; Park J; Kim BY; Kim Y; Kim NG; Shin YI
    Front Immunol; 2023; 14():1122581. PubMed ID: 37063906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-arrestin-2 alleviates rheumatoid arthritis injury by suppressing NLRP3 inflammasome activation and NF- κB pathway in macrophages.
    Cao F; Huang C; Cheng J; He Z
    Bioengineered; 2022 Jan; 13(1):38-47. PubMed ID: 34787064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic mechanism of Psammosilene tunicoides extract on rheumatoid arthritis based on NLRP3 inflammasome].
    He ZM; Huang ZP; Wei YC; Cui M; Qian ZG; Chen HF
    Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4504-4510. PubMed ID: 34581056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis.
    Wu XY; Li KT; Yang HX; Yang B; Lu X; Zhao LD; Fei YY; Chen H; Wang L; Li J; Peng LY; Zheng WJ; Hou Y; Jiang Y; Shi Q; Zhang W; Zhang FC; Zhang JM; Huang B; He W; Zhang X
    J Autoimmun; 2020 Jan; 106():102336. PubMed ID: 31601476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome.
    Dong X; Zheng Z; Lin P; Fu X; Li F; Jiang J; Zhu P
    Cell Mol Immunol; 2020 Mar; 17(3):261-271. PubMed ID: 30911117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.
    Ruscitti P; Cipriani P; Di Benedetto P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Alvaro S; Triolo G; Giacomelli R
    Clin Exp Immunol; 2015 Oct; 182(1):35-44. PubMed ID: 26095630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.